Results 161 to 170 of about 13,546 (186)
Some of the next articles are maybe not open access.
Neuromyelitis optica: an overview
Postgraduate Medical Journal, 2010Abstract Neuromyelitis optica (NMO) is a relapsing inflammatory disorder of the central nervous system that closely resembles multiple sclerosis. This review discusses recent understanding of NMO with reference to epidemiology, clinical spectrum, immunopathology, diagnostic evaluation, clinical course and management.
R, Nandhagopal +2 more
openaire +2 more sources
Treatment of neuromyelitis optica
Current Opinion in Ophthalmology, 2015Neuromyelitis optica (NMO) is an antibody-mediated inflammatory disease of the central nervous system with a predilection for the optic nerves, spinal cord and certain brain regions. It has a distinct pathogenesis relating to aquaporin-4 autoimmunity and complement-mediated injury.
Ivana, Vodopivec +2 more
openaire +2 more sources
Biomarkers for neuromyelitis optica
Clinica Chimica Acta, 2015Neuromyelitis optica (NMO) is an acquired, heterogeneous inflammatory disorder, which is characterized by recurrent optic neuritis and longitudinally extensive spinal cord lesions. The discovery of the serum autoantibody marker, anti-aquaporin 4 (anti-AQP4) antibody, revolutionizes our understanding of pathogenesis of NMO.
Kuo-Hsuan, Chang +3 more
openaire +2 more sources
Biotinidase Deficiency as a Mimic of Neuromyelitis Optica Spectrum Disorder in Childhood
JAMA Neurology, 2021Jonathan D Santoro
exaly
CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
Heliyon, 2021Chihiro Namatame +2 more
exaly
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lancet, The, 2004Sean J Pittock +2 more
exaly
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
Multiple Sclerosis Journal, 2012Su-Hyun Kim, Woojun Kim
exaly